June 19, 2025

Establishing Novel Models of Interdisciplinary Care to Improve Survival Outcomes in Patients With Cancer

Internationally renowned for her decades-long pioneering research in pancreatic cancer, in 2024, Diane M. Simeone, MD, left her positions as the Laura and Isaac Perlmutter Professor of Surgery and Pat...

The ASCO Post

June 19, 2025

Addition of Tumor Treating Fields to Gemcitabine/Nab-Paclitaxel in Locally Advanced Pancreatic Adenocarcinoma

In a phase III trial (PANOVA-3) reported in the Journal of Clinical Oncology, Babiker et al examined the survival benefit of using tumor treating fields with gemcitabine/nab-paclitaxel in patients wit...

The ASCO Post

June 19, 2025

Novel Tri-Specific Antibody Shows Efficacy and Safety in Refractory Myeloma

Findings from a first-in-human phase I trial demonstrated efficacy and a tolerable safety profile for a novel off-the-shelf tri-specific antibody in the treatment of patients with multiple myeloma hig...

The ASCO Post

June 19, 2025

Study Identifies Key LBCL Traits Tied to Greatest Benefit From CD19 CAR T-Cell Therapy

“By identifying the three patient subgroups that have significantly different outcomes following CD19 CAR T-cell therapy, we move toward enhancing treatment selection for clinicians and pave the way f...

The ASCO Post

June 19, 2025

Elevated Cardiac Biomarkers Associated With Increased Cancer Risk

Higher baseline levels of certain cardiac biomarkers were associated with an increased risk of future incidence of cancer, according to findings from a study published in the Journal of the American C...

The ASCO Post

June 18, 2025

FDA Approves Mitomycin Intravesical Solution for Recurrent Low-Grade Intermediate-Risk Non–Muscle-Invasive Bladder Cancer

On June 12, 2025, the U.S. Food and Drug Administration approved mitomycin intravesical solution (Zusduri) for adult patients with recurrent low-grade intermediate-risk non–muscle invasive bladder can...

The ASCO Post

June 17, 2025

Chronicling the Extraordinary Career of Stephen R. Grobmyer, MD, FACS, in Breast Cancer Research, Surgery, and Treatment

In this installment of The ASCO Post’s Living a Full Life series, Stephen R. Grobmyer, MD, FACS, speaks about his clinical and research career in oncology, the challenges and rewards of moving to Abu ...

The ASCO Post

June 17, 2025

Maintenance Therapy With Lurbinectedin Plus Atezolizumab Improves Survival Outcomes in Extensive-Stage Small Cell Lung Cancer

Maintenance treatment with the alkylating agent lurbinectedin plus the monoclonal antibody atezolizumab significantly improved both progression-free survival and overall survival compared with atezoli...

The ASCO Post

June 17, 2025

Study Defines Divergent Molecular Pathways in HPV-Associated vs HPV-Independent Sinonasal Cancers

Findings from a comprehensive genome-wide study of sinonasal squamous cell carcinomas demonstrated that human papillomavirus (HPV) can drive tumorigenesis in some cases, and these tumors exhibit simil...

The ASCO Post